USPTO 2015–2025 USPTO PatentsView US Corporation

VivaLnk, Inc.

USPTO PatentsView assignee record - 16 granted patents across 11 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vivalnk ranks #18,272 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 11 technology areas.

#18,272
of 49,997 US assignees by volume
34th percentile
by Innovation Score (30.4/100)
14.8
avg claims per patent
-86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18272 · US Corporation #18,272 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 16 grants
  • MID-PACK #18,272/49,997
  • PHOTO-FINISH Väderstad Holding AB
  • CPC-FOCUS A61B · 11 areas
  • INNOV-THIN 30.4/100
  • CLAIMS-RICH 14.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Väderstad Holding AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vivalnk’s 30.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Vivalnk

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vivalnk's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Vivalnk?

Each dot is one of Vivalnk’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vivalnk’s own 14.8 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vivalnk vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 15.915.91616.1 51015202530 Granted patents (volume) Avg claims / patent Vermont Slate & Copper Services, Inc. - 16, 16.62Vermont Slate & C…Versata, Inc. - 16, 17.88VersataVertiv Tech Co., Ltd. - 16, 10.81Vertiv TechVidatronic, Inc. - 16, 12.25VidatronicVoxtel, Inc. - 16, 21.62VoxtelVytronUS, Inc. - 16, 24.44VytronusVäderstad Holding AB - 16, 15.88Väderstad Holding…W&W Sens Devices, Inc. - 16, 28.38W&W Sens DevicesVivaLnk, Inc. - 16, 14.81Vivalnk
Vivalnk vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vivalnk's grants concentrate

VivaLnk, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 68.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2020. By volume, Vivalnk sits between Vermont Slate & Copper Services, Inc. and W&W Sens Devices, Inc..

Who files at VivaLnk's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows VivaLnk holds 16 patents at rank #18,270, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near VivaLnk

By rank, the assignees closest to #18,270 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in VivaLnk's primary technology class.

Vivalnk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201620172018201920202021 1
USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
VivaLnk, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 4 25.0%
2017 4 25.0%
2018 4 25.0%
2019 2 12.5%
2020 1 6.3%
2021 1 6.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

VivaLnk, Inc.'s patent record in context - here's where to go next.

  • VivaLnk, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 68.8% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #18,272 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare VivaLnk, Inc. against Vermont Slate & Copper Services, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.